We recently developed a two-compartment. two-parameter tracer kinetic model to estimate the in vivo ligand transport rate (K,) and distribution volume (DV) for the benzodiazepine antagonist [ " CJflumazenil (FMZ) as measured by positron emission tomography (PET). The aim of the present study was to validate that this simplified model provides a stable measure of re gional benzodiazepine receptor availability even when ligand delivery is altered. Six young normal volunteers underwent two PET studies subsequent to intravenous injections of [ 11 C]FMZ. Each FMZ study was immedi ately preceded by measurements of CBF following injec tion of [ 15 0]water. One set of scans (water/FMZ) was acquired under resting conditions and the other set during audiovisual stimulation. Six additional volunteers under-
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We recently developed a two-compartment. two-parameter tracer kinetic model to estimate the in vivo ligand transport rate (K,) and distribution volume (DV) for the benzodiazepine antagonist [ " CJflumazenil (FMZ) as measured by positron emission tomography (PET) . The aim of the present study was to validate that this simplified model provides a stable measure of re gional benzodiazepine receptor availability even when ligand delivery is altered. Six young normal volunteers underwent two PET studies subsequent to intravenous injections of [ 11 C]FMZ. Each FMZ study was immedi ately preceded by measurements of CBF following injec tion of [ 15 0]water. One set of scans (water/FMZ) was acquired under resting conditions and the other set during audiovisual stimulation. Six additional volunteers under-Alterations in the number or function of central benzodiazepine receptors (BZRs) in the brain have been suggested in a variety of neurologic and psy chiatric diseases. Flumazenil (FMZ) is a non subtype-selective central-type BZR antagonist with rapid uptake to the brain and high-affinity binding to the receptors. The distribution of BZRs in the animal brain (Hunkeler et aI., 1981; Moehler and Richards, 1983; Goeders and Kuhar, 1985; d'Argy et aI., 1987; Hantraye et a1., 1988; Richards et a1., 1988) as well as in the postmortem human brain with Huntington's disease (Whitehouse et a1., 1985;  went two FMZ studies under identical resting conditions. Parametric images were analyzed and a comparison of test-retest studies in the stimulation group revealed a sig nificant increase of CBF and K l of FMZ in the occipital cortex evoked by visual activation, whereas no regional changes were noted for the DV of FMZ. No significant changes were noted for either K l or DV of FMZ when comparing studies in the rest-rest setting. The results in dicate that the use of a simple two-compartment model for the tracer kinetic analysis of [ ll C]FMZ makes it pos sible to separate high-affinity binding from altered radio ligand delivery to the human brain. Key Words: Benzodi azepine receptors-Brain-Flumazenil-Positron emis sion tomography-Tracer kinetic modeL Trifiletti et a1. , 1987) has been extensively mapped using the techniques of in vivo and in vitro radio active ligand binding with tritiated FMZ. Positron emission tomography (PET) and lI e-labeled FMZ have also been applied for measurements of recep tor distribution in healthy volunteers (Persson et aI., 1985 (Persson et aI., , 1989 Shinotoh et ai, 1986 Shinotoh et ai, , 1989 Pappata et aI., 1988; Blomqvist et a1., 1990; Price et aI., 1990) , in patients with epilepsy (Savic et a1., 1988) as well as in cases of hepatic encephalopathy for measurements of FMZ uptake (Samson et aI., 1987) .
We recently developed a two-compartment, two parameter tracer kinetic model for the estimation of regional brain BZR density (Koeppe et aI., 1991) . The model includes an intravascular compartment and a single tissue compartment representing the sum of free, nonspecific binding and specific bind ing pools. The technique differs from previous methods in that compartmental modeling and tracer kinetic analysis are employed after single injection studies and pixel-by-pixel maps of ligand transport rate (K1) and distribution volume (DV) are gener ated. DV is considered to represent predominantly specific BZR binding.
The aim of the present study was to validate the assumption that this modeling approach provides a stable measure of regional BZR availability even under conditions of altered ligand delivery to the brain. We scanned normal volunteers in a test retest setting, acquiring data in two subsequent PET studies after injection of [ II C]FMZ. We present the results of subsequent studies performed under resting conditions to evaluate intrasubject variability, and we compare studies acquired under visual stimulation with baseline studies (eyes closed) to evaluate effects of altered radio ligand de livery on the estimated parameters.
METHODS

Subjects
Twelve young healthy volunteers (26 ± 3 years old) took part in the study after undergoing general medical and neurologic examination by a neurologist. The volun teers were free of significant general medical, neurologic, and psychiatric illness and had no family history of first degree relatives with familial neurological or psychiatric disease. They were also screened to exclude history of head trauma with loss of consciousness, drug or alcohol abuse or dependence, smoking, excessive consumption of caffeine, and use of centrally acting medications within 12 months prior to participation. The studies were ap proved by the University of Michigan Institutional Re view Boards and written informed consent was obtained for all studies.
PET imaging and experimental design
A radial artery and cutaneous vein were cannulated for withdrawal of blood samples and for injection of the ra dioisotopes, respectively. The subjects were positioned supine in the gantry of a CTIISiemens 931/08-12 tomo graph. The scanner simultaneously acquires 15 contigu ous transaxial slices covering an � lO-cm axial field of view, with an in-plane spatial resolution of � 7-8 mm full width at half-maximum. A total of 12 volunteers were studied in a test-retest setting after sequential bolus in jections of 22.5 mCi [ ll C]FMZ. The radioisotope was pro vided in a volume of 3-4 ml and was injected over 20 s. One group of six volunteers (rest) underwent two rest studies with their eyes and ears unoccluded in a room with dimmed light. The remaining six volunteers (stimu lation) either watched a video during the entire imaging time of the first study, followed by a rest study with their eyes blindfolded and ears unoccluded (n = 4), or under went the rest study first, followed by the stimulation study (n = 2). Audiovisual stimulation was started 5 min prior to radioisotope injection and the videotapes shown were either of educational nature or contained popular adventure screenplays as selected by the volunteers, in an effort to ensure that the subjects would remain atten tive throughout the study. In both groups the [ ll C]FMZ injections were separated by 100-120 min to allow decay and washout of residual isotope. A dynamic series of PET data (15 frames) and 30-35 arterial blood samples were obtained over 60 min for the FMZ studies. Both FMZ studies in the stimulation group were immediately pre ceded by measurements of CBF following intravenous bolus injection of 50-60 mCi [ 15 0]water. A dynamic se quence of nine frames was acquired over a period of 6 min. The arterial blood concentration was recorded con tinuously from the radial artery using a flow-through plas tic scintillation detector (Hutchins et al. , 1986) . CBF was then estimated by a weighted integral method (Alpert et aI. , 1984) , omitting the first 30 s of data as described by Koeppe et al. (1987) .
Correction of arterial input function for metabolites
The time course of [ II C]FMZ following injection was determined in arterial plasma with the use of an Nal well counter. A total of 13 samples for each study were pro cessed by liquid chromatography using Sep-Pak CI 8 car tridges to separate authentic FMZ from labeled metabo lites as described by Frey et al. (1991) . The arterial blood was centrifuged and the plasma was applied to the col umn. A metabolite and an FMZ fraction were then ob tained for each sample by prewashing the column with 9 ml of a 35% methanol/sodium phosphate buffer solution and 5 ml of 100% methanol, respectively. The separation was corrected for loss of authentic FMZ with the metab olite fraction on the basis of [ 3 H]FMZ added as internal standard to each sample prior to processing. The ratio of [ II C]FMZ to [ II Cl-metabolites was determined in the well counter and the recovery of [ 3 H]FMZ was determined by liquid scintillation spectrometry. The arterial input func tion was then corrected for the metabolite fraction. The presence of labeled metabolites was detectable within 2-3 min after injection and increased with time to account for � 70% of the arterial activity after 15 min.
Realignment of images
Reconstructed images were realigned with the use of small molecular sieve beads as fiduciaries to correct for subject motion during and between scanning sessions. One bead was placed on the forehead and one behind each ear and stayed tightly attached to the scalp during the entire scanning period. Each bead was labeled prior to the radioisotope injection as follows: 6 f,LCi of ll C each prior to a receptor study and 0. 6 f,LCi of 18 F prior to a CBF study. For the realignment of the studies, we used the 7.5to lO-min frame of the first FMZ study as the base orien tation. We then realigned all frames of that study as well as all frames of the retest FMZ study to the standard. In the stimulation group, we additionally realigned all frames of both CBF studies to the 7. 5-to lO-min frame of the first FMZ study. The method applied here corrects for the three translational and three rotational degrees of freedom and all image sets were realigned to within 1 mm and 10, respectively.
Compartmental analysis of [llC]FMZ transport and distribution
The dynamic series of emission scans obtained from the receptor studies was analyzed together with the me-tabolite-corrected arterial input curve on the basis of a two-compartment, two-parameter model. The model con sists of an intravascular compartment and a single tissue compartment accounting for the combined tracer activity of free, nonspecific binding and specific binding pools. The estimated parameters are the ligand transport from blood to brain K 1 (ml blood ml brain -1 min -I ) and the clearance rate from tissue back to blood k2 (min -I ) . The ratio of these two parameters provides an estimate of the ligand's DV in the brain, which is assumed to represent predominantly specific BZR binding. Parametric images of KI and DV were generated for each study on a pixel by-pixel basis using a weighted integral technique similar to that used for the CBF studies.
Data analysis
Regions of interest were determined on the K 1 images obtained from the first FMZ study and were directly su perimposed on the corresponding images of the remaining maps, first and second FMZ study DV images, as well as second study KI maps. For the stimulation group, iden tical regions were also acquired from both sets of CBF images. The regions included the sum of gray or global cortex, as measured from the level of the midcingulum to the level containing the thalamus, the frontal cortex, the occipital cortex, left and right thalamus averaged, left and right caudate averaged, left and right putamen averaged, left and right cerebellar cortex averaged, and the pons.
Mean values for K1, DV, and CBF in all noncerebrocor tical regions analyzed (caudate, putamen, thalamus, cer ebellar cortex, and pons) showed no changes between studies. Relative K I' DV, and CBF values for all regions were expressed as ratios to these noncerebrocortical means to reduce variance. Statistical analysis was applied to both the rest and the stimulation groups separately. It was expected that the studies in the rest group would not reveal any significant changes for either KI or DV between scans. An a priori hypothesis for the stimulation group predicted a signifi cant increase in the visual activation study for transport rate and blood flow to the occipital cortex and possibly other cortical regions when compared with the baseline study of that group, but that no changes would occur for regional DV. Paired Student t tests were applied for com parison of regional values in the test and retest study for both experimental settings. Owing to the large number of regions tested, a confidence level of 99% was required for statistical significance (p < 0.01)
RESULTS
Rest group
Absolute and normalized results obtained for the rest group are summarized in Tables 1 and 2, re spectively. Absolute values for K, (Table 1) were lower throughout the second rest study when com pared with the first study, but reached significance only in the caudate. Changes in DV were also ob served in the second scan (Table 1) ; however, de creases were much smaller and not significant for any region analyzed. The systematic decrease de scribed for K, only is most probably related to the order of the studies and is best explained by differ ent states of anxiety experienced by the volunteers. The unfamiliar setting of a PET scan may induce anxious feelings and in addition increases in CBF that no longer exist by the time of the repeat study. Because the increase is observed across all regions analyzed, this effect is no longer visible after nor malization of the data. The changes observed be tween scans for normalized Kj did not exceed 5% in any region examined ( Fig. lA; Table 2 ). Normal ized regional means for DV revealed no change larger than 3.5% ( Fig. IC; Table 2 ). Coefficients of variation (CaVs) for K, ranged from 8% in the fron tal cortex to 17% in the occipital cortex for absolute data and from 3% in the putamen to 12% in the occipital cortex for normalized data. The Cays for DV ranged from 5% in the global cortex to 21% in the caudate for absolute data and from 3% in the global cortex to 14% in the pons for normalized data. The variability in receptor binding in the pons may be explained by the fact that there are very few BZRs in that region and that the value for DV is very small. Figure 2 shows the parametric images of the Kj and the ligand DV for three tomographic levels through the brain of one young volunteer. Corresponding images were chosen from both stud ies. Given are absolute regional mean values and coefficients of variation (COV) obtained for K I (ml blood ml brain -I min -I ) and DV (ml blood ml brain -I ) in the rest group. a p < 0.01 in a paired, two-tailed Student t test. Given are regional mean values and coefficients of variation (COY) for the rest group. Yalues are normalized to the mean of all noncortical regions analyzed (see text for further details). Paired, two-tailed Student I test revealed that no region reached significance at p = 0.01.
Stimulation group
The visual stimulation induced significant in creases in absolute and relative K \ in the occipital cortex of 20.5% (p < 0.005) and 21. 2% (p < 0.0005), respectively (Tables 3 and 4 ). Owing to the lower COV, the level of significance was higher for nor malized K\ data than for the absolute values. The normalized data additionally demonstrate a signifi cantly higher transport rate (10.2%; p < 0. 005) for Table 4 ). This may be explained by the prominent auditory and visual activation as well as other potential activations that contribute to the K\ value of that region of interest. The absolute data for K\ demonstrate a nonsignificant (p > 0. 01) in crease of 9.4% in the global cortex (Table 3 ). As shown in Table 5 , visual activation also induces sig nificant increases in CBF in the visual and global ; top) and ligand distribution volume (OV; bottom) in the human brain as mea sured by positron emission tomogra ph y. Three tomographic slices through the brain of a volunteer stud ied under resting conditions: first study (left) and second study (right).
Note the radiolabeled molecular sieve beads as fiduciaries.
Rest Rest
cortex of 21.9% (p < 0.005) and 6. 7% (p < 0. 01), respectively. The mean DV did not change when comparing baseline and stimulation study for either absolute or normalized data in any region analyzed (Tables 3 and 4; Fig. lD) . In particular, normalized DV in the occipital cortex changed by < 1 % (Fig. 3) between rest and activation studies. The COVs for absolute KJ and DV were generally higher in the stimulation study than in the baseline study ( Table 3) . Normal ization largely decreased the variability for both studies from COVs for absolute data ranging from 11 to 21% for KJ and from 5 to 22% for DV ( Table  3) to COVs for normalized data of 4-12% for KJ and 3-13% for DV (Table 4 ). Figure 4 shows parametric -images of CBF from eSO]water scans, KJ and DV from FMZ scans at corresponding levels of the rest, and activation scans in one volunteer of the stimu lation group.
DISCUSSION
Alterations in the number or function of BZRs are believed to underlie a variety of neurologic and psy chiatric diseases. There are no animal models avail able for many of these conditions so that clinical and postmortem human observations are central in the investigation of the role of BZRs in neuropath ological states. Radioligand receptor imaging with PET in patients after injection of [ ll C]FMZ allows Given are regional absolute values (means) and coefficients of variation (COV) obtained for K I (ml blood ml brain -I min -I ) and DV (ml blood ml brain -I ) in the stimulation group. direct in vivo measurements of BZR, while main taining physiologic conditions and minimizing the confounding influences of terminal illness and post mortem delay of tissue preservation. The two compartment, two-parameter model applied here differs from previous methods (Persson et aI. , 1985 (Persson et aI. , , 1989 Shinotoh et aI. , 1986; Pappata et aI. , 1988; Savic et aI., 1988; Blomqvist et aI. , 1990; Price et aI. , 1990) in that compartmental modeling and tracer kinetic analysis are employed to generate pixel-by-pixel maps of BZRs from a single ra diotracer injection.
All measures of in vivo ligand distribution are likely to be influenced by a variety of factors that may affect estimates of receptor number and affin ity. Recent studies with [llC]FMZ have shown that administration of pharmacological doses of nonla beled benzodiazepines decreases estimates of re ceptor density (Persson et aI., 1985 (Persson et aI., , 1989 Shinotoh et aI., 1986; Pappata et aI. , 1988; Sa vic et aI. , 1988; Blomqvist et aI., 1990; Price et aI., 1990) . However, demonstration of receptor mediation of ligand bind ing does not prove a quantitative relationship be- tween binding estimates and receptor numbers un der all conditions. For example, alterations in radio ligand transport may also influence estimates of binding (Sawada et aI. , 1990) . Distinction of ligand transport from binding alterations would be of par ticular importance in studies of neuronal diseases such as epilepsy, Huntington's disease, and olivo pontocerebellar atrophy since they may be associ ated with focal reductions in cerebral metabolism and blood flow.
In the present study, visual stimulation was per formed to evaluate the specificity of BZR density measurements with our simplified model when ra dioligand transport is altered. Visual activation has been shown to increase blood flow and glucose me tabolism in the area of the primary visual cortex (Kuhl et aI., 1980; Mazziotta and Phelps, 1984; Min tun et aI. , 1989) . The a priori hypothesis predicted significant focal changes in both CBF and K) be tween studies of the stimulation group but no changes in regional values for DV. The changes ob served when comparing the stimulation study with a baseline study (eyes closed) in six volunteers re vealed significant increases in CBF and KI in the visual cortex as well as in the global cortex, a region of interest that includes primary visual, auditory, and association cortex. No other region analyzed showed a change in normalized K) or CBF of >2.5%. Normalized occipital DV changed by <1% between studies. Student's t tests revealed signifi cance levels for DV in occipital cortex and most other regions of p > 0.5, indicating that there is a very low likelihood that the null hypothesis would be rejected for any of the regions analyzed even if a very large number of subjects were studied. This suggests that, with the model applied, estimates of DV remain stable even if radio ligand transport is altered.
To evaluate intrasubject variability in BZR den sity, we performed test-retest studies in an addi- tional six volunteers under resting conditions fol lowing injection of [IlC]FMZ. The regional COVs obtained for both absolute and normalized K 1 and DV indicated that FMZ studies have a regional in trasubject variability similar to that for measure ments of cerebral glucose metabolism with [ 1 8F]fluorodeoxyglucose and PET. No significant changes were observed for absolute estimates of DV between the rest-rest studies. All KI values throughout the repeat study, however, were de creased when compared with the first study. This order effect may well be due to the anxiety experi- enced by the volunteers during the first study, which may induce a global increase in CBF, as ob served here. To measure this effect in future test retest studies with FMZ, it would be beneficial to perform additional measurements of CBF. After normalization of the data, no differences were ob served in either K l or DV between studies. In conclusion, we were able to demonstrate that a simplified two-compartment, two-parameter tracer kinetic model developed by our laboratory for the quantification of BZR density with e l C]FMZ and PET makes it possible to separate high-affinity ligand binding from altered radioligand delivery to the brain and provides a precise measure of BZR availability in the human brain.
